Comments on: ZymoGenetics Snags $1.1 Billion Partnership With Bristol-Myers For Hepatitis C Drug http://www.xconomy.com/seattle/2009/01/12/zymogenetics-snags-11-billion-partnership-with-bristol-myers-for-hepatitis-c-drug/ Business + Technology in the Exponential Economy Sat, 21 Nov 2009 22:30:41 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: Alliance struck between Bristol-Myers Squibb and Alder Biopharmaceuticals worth US$1 billion « Silico Research http://www.xconomy.com/seattle/2009/01/12/zymogenetics-snags-11-billion-partnership-with-bristol-myers-for-hepatitis-c-drug/comment-page-1/#comment-91868 Alliance struck between Bristol-Myers Squibb and Alder Biopharmaceuticals worth US$1 billion « Silico Research Thu, 12 Nov 2009 12:55:33 +0000 http://www.xconomy.com/?p=8265#comment-91868 [...] alliance is the second big partnership Bristol has signed with a Seattle biotech company this year. In January the company entered an [...] [...] alliance is the second big partnership Bristol has signed with a Seattle biotech company this year. In January the company entered an [...]

]]> By: Bristol-Myers Squibb Enters Hep C Race With Help From ZymoGenetics | Pharmababble http://www.xconomy.com/seattle/2009/01/12/zymogenetics-snags-11-billion-partnership-with-bristol-myers-for-hepatitis-c-drug/comment-page-1/#comment-44389 Bristol-Myers Squibb Enters Hep C Race With Help From ZymoGenetics | Pharmababble Tue, 13 Jan 2009 14:33:46 +0000 http://www.xconomy.com/?p=8265#comment-44389 [...] have time for analysis today but Luke Timmerman at Xconomy has a good one if you’re [...] [...] have time for analysis today but Luke Timmerman at Xconomy has a good one if you’re [...]

]]>